Skip to main content

Oncotelic Therapeutics, Inc.

OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000908259

In the last 90 days, Oncotelic Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding OTLC, Q2 2026

See all superinvestors

No superinvestor reported holding OTLC in Q2 2026.